Burcon Successfully Completes Process Validation Phase of a Customer Contract Research Project
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) has successfully completed the process validation phase of a contract research project for a leading industry peer. This achievement showcases Burcon's technical capabilities and expertise in plant-based proteins. The project, which involved validating a food ingredient process, is now ready for scale-up.
Kip Underwood, Burcon's CEO, emphasized that collaboration is part of their market engagement strategy and creates new business opportunities. Randy Willardsen, Senior VP of Process, expressed readiness for further collaborations in the plant-based protein market.
Burcon continues to leverage its expertise through contract services, with additional projects in the pipeline. The company offers innovative processing solutions to companies looking to innovate and scale in the alternative protein market.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) ha completato con successo la fase di convalida del processo di un progetto di ricerca contrattuale per un importante concorrente del settore. Questo traguardo dimostra le capacità tecniche e l'esperienza di Burcon nelle proteine vegetali. Il progetto, che ha coinvolto la convalida di un processo per ingredienti alimentari, è ora pronto per essere scalato.
Kip Underwood, CEO di Burcon, ha sottolineato che la collaborazione fa parte della loro strategia di coinvolgimento nel mercato e crea nuove opportunità commerciali. Randy Willardsen, VP Senior del Processo, ha espresso la propria disponibilità per ulteriori collaborazioni nel mercato delle proteine vegetali.
Burcon continua a sfruttare la sua esperienza attraverso servizi contrattuali, con ulteriori progetti in cantiere. L'azienda offre soluzioni di elaborazione innovative a imprese che cercano di innovare e scalare nel mercato delle proteine alternative.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) ha completado con éxito la fase de validación del proceso de un proyecto de investigación contratada para un importante competidor de la industria. Este logro demuestra las capacidades técnicas y la experiencia de Burcon en proteínas de origen vegetal. El proyecto, que implicó la validación de un proceso de ingredientes alimentarios, está ahora listo para escalar.
Kip Underwood, CEO de Burcon, enfatizó que la colaboración es parte de su estrategia de involucramiento en el mercado y crea nuevas oportunidades de negocio. Randy Willardsen, Vicepresidente Senior de Procesos, expresó su disposición para más colaboraciones en el mercado de proteínas vegetales.
Burcon continúa aprovechando su experiencia a través de servicios contratados, con proyectos adicionales en desarrollo. La empresa ofrece soluciones de procesamiento innovadoras a las compañías que buscan innovar y escalar en el mercado de proteínas alternativas.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF)는 업계의 주요 경쟁사를 위한 계약 연구 프로젝트의 프로세스 검증 단계를 성공적으로 완료했습니다. 이 성과는 식물 기반 단백질에 대한 Burcon의 기술 능력과 전문성을 보여줍니다. 식품 원료 프로세스의 검증이 포함된 이 프로젝트는 이제 대량 생산을 위한 준비가 완료되었습니다.
Burcon의 CEO인 Kip Underwood는 협력이 시장 참여 전략의 일환이며 새로운 비즈니스 기회를 창출한다고 강조했습니다. 프로세스 분야의 수석 부사장인 Randy Willardsen은 식물 기반 단백질 시장에서 추가 협력에 대한 의지를 표명했습니다.
Burcon은 계약 서비스를 통해 전문성을 지속적으로 활용하고 있으며 추가 프로젝트도 진행 중입니다. 이 회사는 대체 단백질 시장에서 혁신하고 성장하려는 기업에 혁신적인 가공 솔루션을 제공합니다.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) a réussi à terminer la phase de validation de processus d'un projet de recherche contractuel pour un leader du secteur. Cette réalisation met en lumière les capacités techniques et l'expertise de Burcon dans les protéines végétales. Le projet, qui a impliqué la validation d'un processus d'ingrédient alimentaire, est désormais prêt à être étendu.
Kip Underwood, PDG de Burcon, a souligné que la collaboration fait partie de leur stratégie d'engagement sur le marché et crée de nouvelles opportunités commerciales. Randy Willardsen, Vice-Président Senior des Processus, a exprimé sa disponibilité pour des collaborations supplémentaires sur le marché des protéines végétales.
Burcon continue d'exploiter son expertise à travers des services contractuels, avec d'autres projets en préparation. L'entreprise propose des solutions de transformation innovantes aux entreprises cherchant à innover et à croître sur le marché des protéines alternatives.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) hat erfolgreich die Validierungsphase eines Vertragsforschungsprojekts für einen führenden Branchenkollegen abgeschlossen. Dieser Erfolg zeigt Burcons technische Fähigkeiten und Fachwissen im Bereich pflanzenbasierter Proteine. Das Projekt, das die Validierung eines Prozesses für Lebensmittelzutaten umfasste, ist nun bereit für den Ausbau.
Kip Underwood, der CEO von Burcon, betonte, dass Zusammenarbeit Teil ihrer Marktengagementstrategie ist und neue Geschäftsmöglichkeiten schafft. Randy Willardsen, Senior VP für Prozesse, äußerte die Bereitschaft zu weiteren Kooperationen im Markt für pflanzenbasierte Proteine.
Burcon nutzt weiterhin sein Fachwissen durch Vertragsdienstleistungen und hat weitere Projekte in der Pipeline. Das Unternehmen bietet innovative Verarbeitungslösungen für Unternehmen an, die im Markt für alternative Proteine innovativ sein und wachsen möchten.
- Successful completion of process validation phase for a leading industry peer
- Project ready to move into scale-up phase
- Additional contract research projects in the pipeline
- Expansion of service offerings in the plant-based protein market
- None.
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2024) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce the successful completion of the process validation phase for a leading industry peer. Burcon continues to leverage its expertise in food processing through contract services, with additional projects in the pipeline.
"We are proud to have completed this phase of the research project, which highlights Burcon's unique technical capabilities and deep knowledge of plant-based proteins," said Kip Underwood, Burcon's chief executive officer. "Collaboration is a piece of our overall market engagement plan and creates new business opportunities as we continue to expand our service offerings."
The project, which leveraged Burcon's experience and infrastructure to validate a food ingredient process, is now ready to move into the scale-up phase. Burcon continues to work closely with this and other leading industry peers to provide innovative processing solutions. Companies looking to innovate and scale in the rapidly growing alternative protein market can rely on Burcon's expertise to streamline their processes.
"We look forward to further collaborations with industry partners and continuing to play a pivotal role in the evolving plant-based protein market," added Randy Willardsen, Burcon's senior vice president of process. "Our team of experienced food scientists and engineers is ready to take on additional research projects and deliver creative solutions."
For more information or to inquire about Burcon's services, please visit our webpage Burcon Services.
About Burcon NutraScience Corporation
Burcon is a global technology leader in the development of plant-based proteins for foods and beverages. Our proteins exhibit superior functionality, taste and nutrition, making them ideal ingredients for food formulators. With over two decades of experience, Burcon has amassed an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. Burcon is committed to delivering next-generation, best-in-class protein solutions, positioning itself as a key player in the rapidly expanding plant-based market. Supporting the growing trend towards a plant-based diet, Burcon offers sustainable protein ingredients that we believe are better for you and better for the planet. For more information, visit www.burcon.ca.
Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations; and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2024 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.
Industry and Investor Contact
Paul Lam
Director, Investor Relations and Communications
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca www.burcon.ca
Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/225339
FAQ
What milestone did Burcon NutraScience (BRCNF) recently achieve in its contract research project?
How does the completed project phase benefit Burcon NutraScience (BRCNF)?
What is the next step for Burcon NutraScience (BRCNF) in this contract research project?
What services does Burcon NutraScience (BRCNF) offer to companies in the alternative protein market?
